BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 24322017)

  • 21. Evaluation of radiological prognostic factors of hepatic metastases in patients with non-functional pancreatic neuroendocrine tumors.
    Denecke T; Baur AD; Ihm C; Steffen IG; Tischer E; Arsenic R; Pascher A; Wiedenmann B; Pavel M
    Eur J Radiol; 2013 Oct; 82(10):e550-5. PubMed ID: 23891296
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Utility of the quantitative Ki-67 proliferation index and CD56 together in the cytologic diagnosis of small cell lung carcinoma and other lung neuroendocrine tumors.
    Zheng G; Ettinger DS; Maleki Z
    Acta Cytol; 2013; 57(3):281-90. PubMed ID: 23635388
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Primary renal well-differentiated neuroendocrine tumors: report of six cases with an emphasis on the Ki-67 index and mitosis.
    Kim B; Kim HS; Moon KC
    Diagn Pathol; 2019 Feb; 14(1):12. PubMed ID: 30732641
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Liver metastases from neuroendocrine tumours of the gastroenteropancreatic system--therapeutic strategies].
    Auernhammer CJ; Jauch KW; Hoffmann JN
    Zentralbl Chir; 2009 Sep; 134(5):410-7. PubMed ID: 19757340
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Well-differentiated neuroendocrine tumor and osteoporosis: incidental findings?
    Poiană C; Carşote M; Neamţu MC; Avramescu ET; Vasilescu F; Terzea D; Păun D; Trifănescu R; Dănciulescu Miulescu R
    Rom J Morphol Embryol; 2013; 54(4):1169-71. PubMed ID: 24399019
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A nonfunctional neuroendocrine tumor of the pancreas - a case report.
    Mogoantă SŞ; Costache A; Muţiu G; Bungău SG; Ghiluşi M; Grosu F; Vasile M; Vîlcea ID; Gherghinescu MC; Mogoantă L; Ion DA
    Rom J Morphol Embryol; 2015; 56(2):511-9. PubMed ID: 26193221
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Are G3 ENETS neuroendocrine neoplasms heterogeneous?
    Vélayoudom-Céphise FL; Duvillard P; Foucan L; Hadoux J; Chougnet CN; Leboulleux S; Malka D; Guigay J; Goere D; Debaere T; Caramella C; Schlumberger M; Planchard D; Elias D; Ducreux M; Scoazec JY; Baudin E
    Endocr Relat Cancer; 2013 Oct; 20(5):649-57. PubMed ID: 23845449
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Neuroendocrine neoplasm of digestive system with different grades: a clinicopathologic and prognostic study].
    Zhang MH; Liu YH; Luo XL; Lin XT; Zhuang HG
    Zhonghua Bing Li Xue Za Zhi; 2012 Jul; 41(7):448-51. PubMed ID: 22932454
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Liver metastases of small intestine neuroendocrine tumors: Ki-67 heterogeneity and World Health Organization grade discordance with primary tumors.
    Shi C; Gonzalez RS; Zhao Z; Koyama T; Cornish TC; Hande KR; Walker R; Sandler M; Berlin J; Liu EH
    Am J Clin Pathol; 2015 Mar; 143(3):398-404. PubMed ID: 25696798
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The clinical characteristic of 43 cases of neuroendocrine tumors with liver metastases].
    Li P; Yang XO; Qian JM
    Zhonghua Nei Ke Za Zhi; 2012 Apr; 51(4):289-93. PubMed ID: 22781949
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Current status of the histopathological assessment, diagnosis, and reporting of colorectal neuroendocrine tumors: A Web survey from the Japanese Society for Cancer of Colon and Rectum.
    Ikeda K; Kojima M; Saito N; Sakuyama N; Koushi K; Watanabe T; Sugihara K; Akimoto T; Ito M; Ochiai A
    Pathol Int; 2016 Feb; 66(2):94-101. PubMed ID: 26814047
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Neuroendocrine lung tumor with liver metastases and carcinoid syndrome].
    Argibay Vázquez S; Núñez Cambre I; Luna Vega V; Ruibal Morell A
    Med Clin (Barc); 2007 Mar; 128(11):440. PubMed ID: 17394864
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of tumor heterogeneity on the assessment of Ki67 labeling index in well-differentiated neuroendocrine tumors metastatic to the liver: implications for prognostic stratification.
    Yang Z; Tang LH; Klimstra DS
    Am J Surg Pathol; 2011 Jun; 35(6):853-60. PubMed ID: 21566513
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The value of serum chromogranin A as a predictor of tumor burden, therapeutic response, and nomogram-based survival in well-moderate nonfunctional pancreatic neuroendocrine tumors with liver metastases.
    Han X; Zhang C; Tang M; Xu X; Liu L; Ji Y; Pan B; Lou W
    Eur J Gastroenterol Hepatol; 2015 May; 27(5):527-35. PubMed ID: 25822862
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlation of computed tomography imaging features and pathological features of 41 patients with pancreatic neuroendocrine tumors.
    Utsumi M; Umeda Y; Takagi K; Takashi K; Nobuoka D; Yoshida R; Shinoura S; Sadamori H; Yagi T; Fujiwara T
    Hepatogastroenterology; 2015; 62(138):441-6. PubMed ID: 25916078
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nuclear survivin is a powerful novel prognostic marker in gastroenteropancreatic neuroendocrine tumor disease.
    Grabowski P; Griss S; Arnold CN; Hörsch D; Göke R; Arnold R; Heine B; Stein H; Zeitz M; Scherübl H
    Neuroendocrinology; 2005; 81(1):1-9. PubMed ID: 15809513
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuroendocrine pancreatic tumor - diagnosis circumstances, staging and treatment: a case report.
    Jimborean G; Ianoşi ES; Comes AD; Gurzu S; Niţu MF; Lupuţ GD; Mezei T; Borz OC
    Rom J Morphol Embryol; 2015; 56(2):619-22. PubMed ID: 26193240
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The high-grade (WHO G3) pancreatic neuroendocrine tumor category is morphologically and biologically heterogenous and includes both well differentiated and poorly differentiated neoplasms.
    Basturk O; Yang Z; Tang LH; Hruban RH; Adsay V; McCall CM; Krasinskas AM; Jang KT; Frankel WL; Balci S; Sigel C; Klimstra DS
    Am J Surg Pathol; 2015 May; 39(5):683-90. PubMed ID: 25723112
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic stratification of metastatic gastroenteropancreatic neuroendocrine neoplasms by 18F-FDG PET: feasibility of a metabolic grading system.
    Ezziddin S; Adler L; Sabet A; Pöppel TD; Grabellus F; Yüce A; Fischer HP; Simon B; Höller T; Biersack HJ; Nagarajah J
    J Nucl Med; 2014 Aug; 55(8):1260-6. PubMed ID: 24876204
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pathology: Classification and Immunoprofile.
    Blank A; Schmitt A; Perren A
    Front Horm Res; 2015; 44():104-14. PubMed ID: 26303707
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.